NOTV: מכפיל EV/EBITDA Inotiv Corp

Inotiv, Inc. (NOTV) faces severe pressure due to debt obligations and US restrictions on primate imports. However, the recovery of biotech R&D budgets and the expansion of laboratories are driving the growth of this CRO. The linear price action on the EV/EBITDA chart is recorded at 0.00. The business relies on external suppliers for feed and reagents, creating a significant dependency on the reliability of partners' supply chains.
פילוחים אנליטיים של חברת Inotiv, Inc.

This indicator correlates the total enterprise value, including net debt, to earnings before interest, taxes, depreciation, and amortization, allowing for an assessment of the real value of assets without the influence of taxes and debt load. By analyzing the EV/EBITDA chart, investors determine whether the asset is overbought, which is critical for Inotiv, Inc. (NOTV) amid geopolitical market fragmentation and the disruption of laboratory material supply chains.